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The emergence of drug-resistant bacteria is increasing rapidly in all parts of the
world, and the need for new antibiotics is urgent. In our continuous search for
new antimicrobial molecules from under-investigated Arctic marine microorganisms, a
marine fungus belonging to the family Lulworthiaceae (Lulworthiales, Sordariomycetes,
and Ascomycota) was studied. The fungus was isolated from driftwood, cultivated in
liquid medium, and studied for its potential for producing antibacterial compounds.
Through bioactivity-guided isolation, a novel sulfated biarylic naphtho-α-pyrone dimer
was isolated, and its structure was elucidated by spectroscopic methods, including 1D
and 2D NMR and HRMS. The compound, named lulworthinone (1), showed antibacterial
activity against reference strains of Staphylococcus aureus and Streptococcus
agalactiae, as well as several clinical MRSA isolates with MICs in the 1.56–6.25 µg/ml
range. The compound also had antiproliferative activity against human melanoma,
hepatocellular carcinoma, and non-malignant lung fibroblast cell lines, with IC50 values
of 15.5, 27, and 32 µg/ml, respectively. Inhibition of bacterial biofilm formation was
observed, but no eradication of established biofilm could be detected. No antifungal
activity was observed against Candida albicans. During the isolation of 1, the compound
was observed to convert into a structural isomer, 2, under acidic conditions. As 1 and 2
have high structural similarity, NMR data acquired for 2 were used to aid in the structure
elucidation of 1. To the best of our knowledge, lulworthinone (1) represents the first new
bioactive secondary metabolite isolated from the marine fungal order Lulworthiales.
Keywords: antibacterial, marine fungi sensu stricto, Lulworthiales, lulworthinone, MRSA, natural product,
mycology, natural product artifact
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INTRODUCTION
Antimicrobial resistance is quickly developing as a worldwide
threat, causing problems not only in the general community
but also in healthcare facilities. Infections caused by methicillin-
resistant Staphylococcus aureus (MRSA) has become a worldwide
health menace (WHO, 2014). There is an urgent need to
develop new antibiotics to fight these resistant microbes. The
fungal kingdom has historically played an important role in
the discovery and development of antibiotics and other drugs
against non-infective diseases (Demain, 2014). The penicillins
and cephalosporins are examples of important antibiotics isolated
from fungi (Demain, 2014), from the genera Penicillium and
Sarocladium (one syn. Cephalosporium), respectively. In marine
natural product discovery, the genera Aspergillus and Penicillium
have proven to be the most prolific producers of new compounds
with biological activities (Imhoff, 2016). As the focus of marine
natural product discovery has been on mold fungi belonging to
the few genera mentioned above, the strictly marine clades of
fungi remain understudied (Overy et al., 2014).
One of the understudied marine clades include the fungal
order Lulworthiales from which no secondary metabolites have
been reported since the discovery of the type genus and species,
Lulworthia fucicola, in the beginning of the twentieth century
(Sutherland, 1915). The order Lulworthiales was established
in 2000 to accommodate the new family Lulworthiaceae in
the class Sordariomycetes (Kohlmeyer et al., 2000). More
recently, a new subclass, Lulworthiomycetidae, was described
containing the orders Lulworthiales and Koralionastetales
(Maharachchikumbura et al., 2015). Lulworthiaceae is the sole
family in the Lulworthiales order, and Lulworthiaceae spp.
are regarded as strictly marine species, which include the
following genera: Cumulospora, Halazoon, Hydea, Kohlmeyerella,
Lulwoana, Lulworthia, Lindra, Matsusporium, and Moleospora
(Poli et al., 2020). Recently, a novel genus was introduced to the
Lulworthiaceae, Paralulworthia, with two new species described,
Paralulworthia gigaspora and Paralulworthia posidoniae (Poli
et al., 2020). Hyde et al. (2020) also included the following genera
in the family: Haloguignardia, Lolwoidea, Moromyces, Orbimyces,
Rostrupiella, and Sammeyersia.
Fungi in the family Lulworthiaceae have been isolated from a
variety of substrates and environments. Some examples include
corals (Góes-Neto et al., 2020), plants located in salt marches
(Calado et al., 2019), seagrass (Poli et al., 2020), Portuguese
marinas (Azevedo et al., 2017), sandy beaches of the Cozumel
island in Mexico (Velez et al., 2015), brown seaweed (Zuccaro
et al., 2008), and driftwood (Rämä et al., 2014). The distribution
of Lulworthiales fungi in marine habitats has been studied
throughout the history of marine mycology (Johnson, 1958;
Kohlmeyer et al., 2000; Koch et al., 2007; Rämä et al., 2014;
Azevedo et al., 2017; Góes-Neto et al., 2020), but the biosynthetic
potential of these fungi has not been investigated, most likely due
to the special knowledge required for their isolation (Overy et al.,
2019) and low growth rates.
In this paper, we report the isolation of a new antibacterial
compound, lulworthinone (1), from a liquid culture of a marine
fungus belonging to Lulworthiaceae (isolate 067bN1.2). We
elucidate the structure of 1 and study its bioactivity against
prokaryotic and eukaryotic cells with focus on antibacterial
activity against clinical MRSA isolates. Compound 1 represents
the first secondary metabolite reported from this order of fungi,
and to the best of our knowledge, the first biarylic dimeric
naphtho-α-pyrone substituted with a sulfate group. Initially,
the compound was isolated using preparative HPLC under
acidic conditions. As this procedure caused significant wear
and tear to the equipment, the isolation was switched to flash
chromatography under neutral conditions. When comparing
spectroscopic data from the two samples, one isolated at neutral
and one at acidic conditions, structural differences were observed.
It was later determined that 1 concerts into the artifact 2 under
acidic conditions.
MATERIALS AND METHODS
Biological Material and Phylogenetic
Analysis of Isolate 067bN1.2
The marine fungus 067bN1.2 was isolated from a dead pine
(Pinus sp.) collected in the splash zone in Kongsfjord, Berlevåg
Norway in 2010. The isolate grew from a small wooden cube
plated onto agar medium (specified below) during a campaign
to study wood-inhabiting fungi of 50 intertidal and sea-floor logs
along the Northern Norwegian coast, where Lulworthiales was
one of the five most frequent orders isolated (Rämä et al., 2014).
The fungus was subcultured and DNA sequenced, and the fungus
was phylogenetically placed in the Lulworthiales order (isolate
TR498 represents 067bN1.2 in Rämä et al., 2014). At the time
of the publication (2014), the closest match from Blast, based
on a 5.8S/large ribosomal subunit (LSU) dataset, was Lulworthia
medusa (LSU sequence: AF195637). The following primer pairs
were used for the internal transcribed spacer (ITS), LSU and
small ribosomal subunit (SSU) sequencing, respectively: ITS5-
ITS4 (White et al., 1990), LR0R-LR5 (Vilgalys and Hester, 1990;
Rehner and Samuels, 1994), and NS1-NS4 (White et al., 1990).
The ITS, LSU, and SSU sequences are deposited in GenBank
under the following accessions: MW377595, MW375591, and
MW375590. The mycelium of the fungus was preserved on pieces
of agar in 20% glycerol solution at−80◦C.
To identify the isolate 067bN1.2 growing as an asexual morph
in culture and determine its systematic position within the order
Lulworthiales, a phylogenetic analysis was run using a dataset
consisting of nrSSU, nrITS, and nrLSU sequences. The reference
sequences included in the analyses were sampled based on
recent phylogenetic studies focusing on Lulworthiales (Azevedo
et al., 2017; Poli et al., 2020) and retrieved from Genbank
(Supplementary Table 1). Sequences for each gene were aligned
individually using the E-INS-I and G-INS-I algorithms of
MAFFT v7.388 (Katoh et al., 2002; Katoh and Standley, 2013)
in Geneious Prime v.11.0.4 followed by manual adjustment. The
concatenated dataset consisting of SSU, 5.8S, and LSU sequences
and having a length of 2,270 nt was run through PartitionFinder
v2.1.1 (Lanfear et al., 2017) to test for best-fit partitioning
schemes and evolutionary models with the following settings:
models MrBayes, linked branch lengths, greedy search, and AIC
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and BIC model selection (Lanfear et al., 2012). This suggested
three partitions with varying models: symmetrical model with
equal base frequencies and gamma distributed rate variation
among sites without (SYM+G) and with (SYM+I+G) invariable
sites and general time reversible model with variable base
frequencies and gamma distributed rate variation among sites
(GTR+G). A phylogenetic analysis was set up applying suggested
models using Parallel-MPI MrBayes v3.2.7a with beagle, and
was run for 5,000,000 generations or until average standard
deviation of split frequencies was below 0.0009 with sampling
each of the 2,500 generations (Ronquist et al., 2012). In addition,
RAxML in Geneious v10.2.3 was run with the same partitions
under GTRCAT and GTRGAMMA using rapid-bootstrapping
algorithm with 2,000 replicates with search for best scoring ML
tree (Stamatakis, 2006). The resulting MrBayes tree was similar
to the RAxML tree, excluding some of the basal nodes within
Lulworthiaceae shown as polytomies in the MrBayes tree.
Fungal Cultivation and Extraction
For the purpose of this study, the fungal isolate was plated from
glycerol stock and grown on nutrient-poor malt agar with sea
salts [4 g/L malt extract (Moss Malt Extrakt, Jensen & Co AS),
40 g/L sea salts (S9883, Sigma-Aldrich), 15 g/L agar (A1296,
Sigma-Aldrich) and Milli-Q R© H2O] until the growth covered the
entire agar plate (approximately 40 days). Milli-Q R© H2O was
produced with the in-house Milli-Q R© system. One-half of the
agar plate covered in mycelium was used to inoculate each liquid
culture, in malt medium with added sea salts (4 g/L malt extract,
40 g/L sea salts). Two cultures of 200 ml were inoculated and
incubated for 107 days at static conditions and 13◦C. Before
the addition of resin for extraction, mycelium was taken from
the culture for inoculation of another round of cultures. The
second cultivation contained four cultures with 250 ml of malt
extract medium supplemented with sea salts and cultivated under
the same conditions for 83 days. The total culture volume used
for the extraction of 1 was 1.4 L. The cultures were extracted
using Diaion HP-20 resin (13607, Supelco) and methanol (20864,
HPLC grade, VWR) as described previously (Kristoffersen et al.,
2018; Schneider et al., 2020). The extract was dried in a rotary
evaporator at 40◦C under reduced pressure and stored at−20◦C.
Dereplication
As part of our ongoing search for antimicrobial compounds,
extracts of marine microorganisms are fractioned into six
fractions using flash chromatography, as previously described
(Schneider et al., 2020). When we investigated the antibacterial
potential of fractions produced from several understudied marine
fungi, one fraction from isolate 067bN1.2 piqued our interest
due to its antibacterial activity. In the active fraction, 1 was the
dominating peak. The monoisotopic mass, calculated elemental
composition and fragmentation pattern of 1 was determined
using UHPLC-ESI-HRMS. UHPLC-ESI-HRMS was performed
with positive ionization mode, using an Acquity I-class UPLC
with an Acquity UPLC C18 column (1.7 µm, 2.1 mm× 100 mm),
coupled to a PDA detector and a Vion IMS QToF (all from
Waters). Compounds were eluted with a gradient over 12 min,
from 10 to 90% acetonitrile (LiChrosolv, 1.00029, Supelco) with
0.1% formic acid (Sigma-Aldrich) in Milli-Q H2O and a flow
rate of 0.45 ml/min. Waters UNIFI 1.9.4 Scientific Information
System was used to process and analyze the data. Elemental
compositions of compounds in the samples were used to search
relevant databases, such as Chemspider, in order to identify
known compounds. Since the calculated elemental composition
gave no hits in database searches, 1 was nominated for isolation.
Isolation of 1
Initial attempts to isolate 1 was performed using mass guided
preparative HPLC. This strategy proved difficult due to extensive
binding of the compound to an Atlantis Prep C18 (10 µM,
10 × 250 mm) (Waters) column, leading to inefficient isolation
and column contamination. The preparative system and mobile
phases used were as previously described (Schneider et al., 2020).
The resulting sample (referred to as compound 2) was later used
to assist in structure elucidation of compound 1.
To avoid wear and tear of the preparative HPLC system,
attempts were made to isolate 1 using flash chromatography.
The dried extract was dissolved in 90% methanol, and 2 g of
Diaion HP-20SS (13615, Supelco) was added before removing the
solvent under reduced pressure. Flash columns were prepared
as previously described (Kristoffersen et al., 2018). The column
was equilibrated using 5% methanol, before the dried extract-
Diaion HP-20SS mixture was applied to the top of the column
(maximum 2 g of extract per round). The fractionation was
performed on a Biotage SP4TM system (Biotage) with a flow
rate of 12 ml/min and a stepwise gradient from 5 to 100%
methanol over 32 min. The following stepwise elution method
was used: methanol:water (5:95, 25:75, 50:50, 75:25, 6 min per
step, resulting in 12 fractions) followed by methanol (100%
over 12 min, resulting in six fractions). The MeOH fractions
were analyzed using UHPLC-ESI-HRMS. In the second fraction
eluting at 100% MeOH, 1 was the dominating peak and was
submitted for NMR and bioactivity analysis. The sample of 1
was therefore produced by pooling the second fraction eluting
at 100% MeOH from multiple rounds of flash fractionation and
drying the resulting volume under reduced pressure.
Structure Elucidation of 1
The structure of 1 was established by 1D and 2D NMR
experiments. NMR spectra were acquired in DMSO-d6 and
methanol-d3 on a Bruker Avance III HD spectrometer operating
at 600 MHz for protons, equipped with an inverse TCI
probe cryogenically enhanced for 1H, 13C, and 2H. All NMR
spectra were acquired at 298 K, in 3-mm solvent matched
Shigemi tubes using standard pulse programs for proton, carbon,
HSQC, HMBC, HMQC (J = 4–5 Hz), COSY, NOESY, ROESY
and 1,1-ADEQUATE experiments with gradient selection and
adiabatic versions where applicable. 1H/13C chemical shifts
were referenced to the residual solvent peak (δH = 2.50 PPM,
δC = 39.52 PPM for DMSO). All data were acquired and
processed using Topspin 3.5pl7 (Bruker Biospin) including the
structure elucidation module CMC-se v. 2.5.1. 13C prediction
was done using Mestrelabs MestReNova software version 14.2.0-
26256 with the Modgraph NMRPredict Desktop. Optical rotation
Frontiers in Microbiology | www.frontiersin.org 3 October 2021 | Volume 12 | Article 730740
fmicb-12-730740 September 27, 2021 Time: 17:34 # 4
Jenssen et al. Lulworthinone, a New Antibacterial Naphthopyrone
data were obtained using an AA-10R automatic polarimeter
(Optical Activity LTD).
Lulworthinone (1): green colored film. [α]20D -120 ± 0.02
(c 0.2 DMSO). 1H and 13C NMR spectroscopic data,
Supplementary Table 3. HRESIMS m/z 741.2204 [M+H]+




The Minimal Inhibitory Concentration (MIC) of 1 against a
panel of Gram-positive and Gram-negative reference bacteria
was determined by broth microdilution, at final concentrations
0.2–100 µg/ml (twofold dilution series). The experiments were
performed with three technical replicates. The panel of reference
bacteria consisted of the following strains: S. aureus (ATCC
25923), MRSA (ATCC 33591), Escherichia coli (ATCC 25922),
Pseudomonas aeruginosa (ATCC 27853), Enterococcus faecalis
(ATCC 29212), and Streptococcus agalactiae (ATCC 12386), all
strains from LGC Standards (Teddington). Briefly, the bacteria
were inoculated from freeze stock onto blood agar plates
(University Hospital of North Norway) and transferred to liquid
medium for overnight incubation at 37◦C. S. aureus, E. coli, and
P. aeruginosa were grown in Brain Heart Infusion medium (BHI,
53286, Sigma-Aldrich), and E. faecalis and S. agalactiae were
grown in DifcoTM Mueller Hinton medium (MH, 275730, BD
Biosciences). After overnight incubation in the respective media,
the bacteria were brought to exponential growth by addition of
fresh media, and incubated to reach a turbidity of 0.5 McFarland
standard. The bacteria were diluted in their respective media
1:1,000 prior to addition. Subsequently, the bacteria were added
to 96-well microtiter plates at 50 µl/well. A mixture of 50 µl
of autoclaved Milli-Q R© H2O and 50 µl fresh autoclaved media
was used as negative control, and 50 µl of autoclaved Milli-
Q R© H2O was added to 50 µl of bacteria suspension as growth
control. The compound was diluted in DMSO and autoclaved
Milli-Q R© H2O (highest concentration of DMSO in the assay
was 0.5%), and 50 µl was added to the bacterial suspension.
Final volume in the wells was 100 µl. The plates were incubated
overnight at 37◦C. After incubation, growth was measured by
absorbance at 600 nm with 1420 Multilabel Counter VICTOR3TM
(Perkin Elmer). Assay controls with gentamicin in a dilution
series are routinely run, as well as routine counting of CFUs for
each bacterium. For the strains where the compound displayed
activity, the MIC was determined with three biological replicates
each containing three technical replicates (n = 9). The lowest
concentration of 1 that completely inhibited the growth of the
bacteria was determined as the MIC.
To investigate if 1 had a bacteriocidal or bacteriostatic
effect on S. aureus and S. agalactiae, the compound was
inoculated together with the bacteria, as described above, and
after overnight incubation, the inoculum was plated onto agar
and incubated overnight at 37◦C. The experiment was done with
12.5 and 25 µg/ml concentrations of 1 in triplicate, with two
biological replicates (n = 6). Inspired by Zheng et al. (2007), we
tested 1, together with reserpine (broad spectrum efflux pump
inhibitor) against the Gram-negative reference strains E. coli and
P. aeruginosa. The assay was conducted as described above, with
reserpine (L03506, Thermo Fisher Scientific) added to a final
concentration of 20 µg/ml.
Minimal Inhibitory Concentration
Determination Against Clinical Bacterial
Isolates
Initial testing of 1 was conducted against a panel containing
clinically relevant antibiotic-resistant bacteria: Gram-positive
MRSA, vancomycin-resistant Enterococcus faecium (VRE), and
Gram-negative bacteria resistant to extended-spectrum beta-
lactamases as well as carbapenemases (ESBL-Carba) (detailed
information about the clinical isolates can be found in
Supplementary Table 2). The initial testing was conducted at one
concentration, 100 µg/ml.
The final antibacterial testing of 1 was executed using the
five clinical MRSA isolates and the VRE isolates (Supplementary
Table 2). The isolates were tested by broth microdilution
according to the Clinical Laboratory Standard Institute (CLSI)
(2012) method MO7-A9. In brief, 1 was solubilized with 100%
DMSO and diluted with autoclaved Milli-Q R© H2O to prepare a
200 µg/ml working solution. The final DMSO concentration did
not exceed 1% to exclude any artificial influence on the assay.
The bacterial inoculum was prepared to contain 1× 106 CFU/ml
in cationic-adjusted BBLTM Mueller-Hinton II broth (BD). The
inoculum was mixed in a 1:1 ratio with the working solution of
1 (twofold dilutions, ranging from 0.2 to 100 µg/ml) for a final
amount of 5 × 105 CFU/ml in each well of a 96-well round-
bottom polypropylene plate (Greiner Bio-One GmbH). Growth
control (without compound) and sterility control (without
bacteria) were included for each strain. Each strain was tested
in three independent biological replicates with four technical
replicates on consecutive days. As quality assurance for the assay,
the protocol was also performed with E. coli ATCC 25922 using
Gentamicin (Merck Life Science) as a reference antibiotic. The
96-well plates were incubated at 37◦C for 24 h without shaking.
The MIC values were defined as the lowest concentration
of 1 resulting in no visual bacterial growth, determined by
visual inspection and 600 nm absorbance measurements with
CLARIOstar plate reader (BMG LABTECH).
Inhibition of Biofilm Production and
Eradication of Established Biofilm
Inhibition of biofilm production by 1 of Staphylococcus
epidermidis (ATCC 35984, LGC Standards) was determined at
final concentrations 0.2–100 µg/ml (twofold dilution series).
Briefly, the bacteria were inoculated from freeze stock onto
blood agar plates (University Hospital of North Norway) and
transferred to tryptic soy broth (TSB, 22092, Sigma-Aldrich)
for overnight incubation at 37◦C. The overnight cultures were
subsequently diluted 1:100 in fresh TSB with 1% glucose and
added to 96-well microtiter plates, 50 µl/well. Positive control
was S. epidermidis in fresh media with glucose, and negative
control was a non-biofilm producing Staphylococcus haemolyticus
(clinical isolate 8-7A, University Hospital of North Norway) in
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fresh media with glucose. The compound was diluted in DMSO
and autoclaved Milli-Q R© H2O (highest concentration of DMSO
in the assay was 0.5%), and 50 µl was added to the bacterial
suspension. Final volume in the wells was 100 µl. The plates
were incubated at 37◦C overnight. Growth inhibition of the
bacterium was determined by visual inspection of the plates prior
to further treatment. The bacterial suspension was poured out
and the biofilm was fixated by heat, before adding 70 µl of 0.1%
crystal violet solution (V5265, Sigma-Aldrich) and staining for
5 min. The crystal violet solution was removed and the wells
were washed with water before the plates were dried by heat.
The bound crystal violet was dissolved in 70 µl of 70% ethanol,
and the presence of violet color, indicating biofilm formation,
was measured at 600 nm absorbance using a 1420 Multilabel
Counter VICTOR3TM reader. Percent biofilm formation was
calculated using the equation below. The data were visualized
using GraphPad Prism 8.4.2, and the built-in ROUT method was
used to detect and remove outliers from the dataset (Q = 1%).
Percent (%) biofilm formation
=
(absorbance treated wells− absorbance negative control)
(absorbance positive control− absorbance negative control)
× 100 (1)
To determine whether 1 could eradicate biofilm established
by S. epidermidis, a modified biofilm inhibition assay protocol
was performed. Here, the bacteria were grown overnight in a
microtiter plate to allow the biofilm to be established prior to
the addition of 1. After addition of 1, the plates are incubated
overnight. Following this, the biofilm was fixated and colored and
results were read as stated above. The experiment was conducted
once with three technical replicates with concentrations of 0.2–
100 µg/ml (twofold dilution series).
Determination of Antiproliferative
Activity Toward Human Cell Lines
The antiproliferative activities of 1 was evaluated against
the melanoma cell line A2058 (ATCC, CRL-11147TM), the
hepatocellular carcinoma cell line HepG2 (ATCC, HB-8065TM),
and the non-malignant lung fibroblast cell line MRC5 (ATCC,
CCL-171TM) in a MTS in vitro cell proliferation assay. The
compound was tested in concentrations from 6.3 to 100 µg/ml
against all cell lines, with three biological replicates each
containing three technical replicates (n = 9). A2058 was cultured
and assayed in Dulbecco’s Modified Eagle’s Medium (D-MEM,
D6171, Sigma-Aldrich). HepG2 was cultured and assayed in
MEM Earle’s (F0325, Biochrom) supplemented with 5 ml of non-
essential amino acids (K0293, Biochrom) and 1 mM sodium
pyruvate (L0473, Biochrom). MRC5 was cultured and assayed in
MEM Eagle (M7278, Sigma-Aldrich) supplemented with 5 ml of
non-essential amino acids, 1 mM sodium pyruvate, and 0.15%
(w/v) sodium bicarbonate (L1713, Biochrom). In addition, all
media were supplemented with 10% fetal bovine serum (FBS,
S1810, Biowest), 10 µg/ml gentamicin (A2712, Biochrom), and
5 ml of glutamine stable (200 mM per 500 ml medium, X0551,
Biowest). Briefly, the cells were seeded in 96-well microtiter plates
(Nunclon Delta Surface, VWR) at 2,000 cells/well for A2058,
4,000 cells/well for MRC5, and 20,000 cells/well for HepG2.
After incubation for 24 h in 5% CO2 at 37◦C, the media was
replaced and compound was added, generating a total volume of
100 µl/well. A2058 and MRC5 were incubated for 72 h before
assaying, and HepG2 for 24 h. Subsequently, 10 µl of CellTiter
96 AQueous One Solution Reagent (G358B, Promega) was added
to each well and the plates were incubated for 1 h at 37◦C.
Following this, the absorbance was measured at 485 nm with
a DTX 880 multimode detector (Beckman Coulter). Negative
controls were cells assayed with their respective cell media, and
positive controls were cells treated with 10% DMSO (D4540,
Sigma-Aldrich). Percent cell survival was calculated using the
equation below. The data were visualized using GraphPad Prism
8.4.2 and IC50 was calculated. The built-in ROUT method was
used to detect and remove outliers from the dataset (Q = 1%).
Percent (%) cell survival :
(absorbance treated wells− absorbance positive control)
(absorbance negative control− absorbance positive control)
×100 (2)
Minimal Inhibitory Concentration
Determination Against Candida albicans
The MIC of 1 was determined by broth microdilution
against C. albicans (ATCC 90028, LGC Standards), at final
concentrations of 0.2–100 µg/ml (twofold dilution series). The
experiment was performed as one biological replicate, with
three technical replicates (n = 3). Briefly, the fungus was
inoculated from freeze stock onto potato dextrose agar [24 g/L
potato dextrose broth (P6685, Sigma-Aldrich), 15 g/L agar
(A1296, Sigma-Aldrich)] and incubated overnight at 37◦C. From
the overnight culture, five to eight colonies were transferred
to 5 ml of sterile 0.9% NaCl, before the cell density was
adjusted to 1–5 × 106 cells/ml by adding 0.9% NaCl. The cell
density was evaluated with 0.5 McFarland standard (Remel 0.5
McFarland Equivalence Turbidity Standard, 10026732, Thermo
Fisher Scientific). The fungal suspension was further diluted 1:50,
and then 1:20 (1–5 × 103 CFU/ml) in RPMI medium (R7755,
Sigma-Aldrich) with 0.165 mol/L MOPS (M3183, Sigma-Aldrich)
and 10.25 ml of L-glutamine. The compound was added to
the microtiter plate together with the fungal suspension (1:1),
to a final volume of 200 µl. The final concentration of fungal
cells was 0.5–2.5 × 103 CFU/ml. Absorbance in the wells was
measured with 1420 Multilabel Counter VICTOR3TM right after
addition of compound, after 24 h and after 48 h. The plates were
incubated at 37◦C. Amphotericin B was used as negative control
at final concentration 8 µg/ml. Growth control contained fungal
suspension and autoclaved Milli-Q R© H2O.
RESULTS
Systematic Placement of the Fungal
Isolate 067bN1.2
Due to lack of distinct morphological characters of the
cultured asexual morph and closely related reference sequences
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in GenBank, the fungus is identified to family level, as
Lulworthiaceae sp., for the purpose of this study. A phylogenetic
study was carried out with 28 taxa (including outgroups and
isolate 067bN1.2), all representing different species, as shown in
Figure 1. The combined dataset of 5.8S, SSU, and LSU had an
aligned length of 2,270 characters, and phylogenetic inference
was estimated using both Maximum Likelihood and Bayesian
Inference criteria. The isolate producing 1, 067bN1.2, was placed
on its own branch within the Lulworthiaceae, forming a sister
clade to the clade including Halazoon fuscus, Lulworthia medusa,
Lulworthia cf. purpurea and Halazoon melhae. Sequences of
Koralionastes ellipticus were included to exclude the possibility
that the isolate 067bN1.2 is part of the family Koralionastetaceae.
Koralionastes ellipticus was placed outside of Lulworthiaceae.
Isolation and Structure Elucidation
Compound 1 was selected for isolation due to its antibacterial
activity in an initial screen of fractions from several understudied
marine fungi. Compound 1 was the dominating peak in the
active fraction from fungal isolate 067bN1.2 Lulworthiaceae
sp., and subsequently the fungus was re-cultivated, cultures
were extracted, and the compound was isolated using RP flash
chromatography. The extraction of 1.4 L of fungal culture yielded
1,017.2 mg of extract.
Initially, attempts were made to isolate the compound
using preparative HPLC. This strategy had several drawbacks,
including unfavorable behavior of the compound in the
preparative column. This resulted in the compound eluting over
several minutes (band broadening) and carryover. A batch of the
compound was, however, retrieved using this strategy, resulting
in a compound later determined to be a structural isomer and
artifact of compound 1 (referred to as 2 throughout this article),
produced due to the acidic conditions in the mobile phase. The
structures of 1 and 2 can be seen in Figure 2.
Flash chromatography was better suited for the isolation of
1. This isolation strategy yielded 63.8 mg of 1, corresponding
to a yield of ∼45 mg/L culture medium. Compound 1 was
obtained as a green colored substance. The molecular formula
was calculated to be C37H40O14S by UHPLC-ESI-HRMS (m/z
741.2204 [M+H]+) (calculated as C37H41O14S, 741.2217),
suggesting 18 degrees of unsaturation. The low-energy collision
mass spectrum of 1 can be seen in Supplementary Figure 2.
MS signals of a neutral loss of 80 Da (ESI+) was observed,
indicating the presence of a sulfate group in the structure. The
UV absorption maxima were 224, 260, and 373 nm, which
corresponded well with the previously published dinapinones
(Kawaguchi et al., 2013). The UV-vis spectrum for 1 can
be seen in Supplementary Figure 3. The IR spectrum of 1
displayed absorption bands for sulfoxide (S=O, 1,002 cm−1),
aromatic alkene (C=C, 1542 and 1,618 cm−1), carbonyl (C=O,
1,645 cm−1), alkane (C-H, 2,857 cm−1), aromatic alkene (C-
H, 2926 cm−1), and hydroxyl (C-OH, 3455 cm−1) bonds. After
isolation, the structure of 1 (Figure 2) was elucidated by 1D and
2D NMR experiments (Supplementary Figures 4–16).
FIGURE 1 | Maximum Likelihood tree (RAxML) from the combined analysis of 5.8S, SSU, and LSU from isolates of Lulworthiaceae. One isolate from
Koralionastetaceae was included, and four strains as outgroups. Node support is given as Bootstrap support values at the nodes, and posterior probabilities are
included where the branching was alike (BS/PP). The isolate under investigation, Lulwortihaceae_067bN1.2, is highlighted in bold. Due to topological similarity only
the ML tree is shown here containing both Bayesian posterior probabilities and Bootstrap support values. Bayesian Inference tree can be found in Supplementary
Figure 1. – indicates that the node is missing in the Bayesian analysis. No support value is given to the node separating the outgroup taxa from the ingroup in ML
analysis.
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FIGURE 2 | Structures of 1 and 2.
Initial structure elucidation was made on the sample isolated
by preparative HPLC with formic acid present in the mobile
phases (compound 2). The established molecular formula
suggested a highly conjugated system. The purity of 2 was
estimated to be ∼80% from a quantitative proton spectrum with
respect to non-solvent impurities (Supplementary Figure 4).
Four singlet protons were identified in the aromatic region, along
with three O-CH signals at ∼4.5 ppm with complex couplings
along with a methoxy singlet at 3.77 ppm. Furthermore,
five hydroxyl protons were identified; three between 9.5 and
10.0 ppm, and two between 13.5 and 14.0 ppm. The deshielded
nature of the latter sets them apart from the other hydroxyls
and suggests they may be involved in an angled intramolecular
hydrogen bond, which is commonly seen for keto-enol pair
configurations such as this. All 37 carbons could be identified
by 1D 13C NMR (Supplementary Figure 5), which showed
2 to contain a large number of aromatic quaternary carbons,
two ester-like carbonyls, along with 10 peaks in the aliphatic
region (Table 1).
HSQC, HMBC, and 1,1-ADEQUATE spectra (Supplementary
Figures 6, 7) allowed the identification of two substituted
napthopyrone-like moieties, as well as two five-membered
aliphatic chains (denoted C15-C11 and C15’-C11’, respectively),
which were fully assigned using a combination of HSQC-TOCSY,
TOCSY, COSY, and HMBC (Figure 3i). The aliphatic chains
were determined to be attached at the C10 position of the
napthopyrone-like moieties by tracing the spin system into H9
and H9’, respectively, and supported by multiple long-range 1H-
13C correlations. The C2 and C2’ carbonyls could be directly
assigned from long-range couplings from the 10/10’ position,
but the hydroxyl carrying carbons in positions 3/3’ and 4/4’
could only be assigned through weak 4JCH correlations from the
aromatic protons (Figure 3iii).
The OH-4 and OH-6 could be assigned based on NOE
correlations between OH-6 and both H5 and H7, while OH-
4 only displayed correlations with H5. The OH-3 and OH-
3’ are predicted to have more deshielded chemical shifts due
to their proximity to the carbonyl moiety and a probable
intramolecular hydrogen bond—however, it was not possible to
individually distinguish OH3 and OH-3’ due to the absence of
any correlations in NOESY, ROESY, and HMBC spectra. Thus,
four fragments could initially be elucidated (Figure 3i). A weak
4JC8H7 ′ correlation could be detected, linking fragment A to
fragment B (Figure 3i) at the C8 and C5’ positions, respectively,
and thus the only remaining ambiguity is the position of the -
SO3− group vis-à-vis the remaining -OH in the 9’ or 4’ positions.
The absence of NOEs and COSY correlations between OH-4’ and
H9’ suggests that it is positioned at C4’ with the sulfate positioned
at C9’ (Figure 3ii). The 3JHH coupling constant between H9’
and H10’ was measured to be 2.0 Hz from line shape fitting the
splitting of H9’, indicating that these protons are at a significantly
offset dihedral angle to one another—thus suggesting a relative
R/S or S/R configuration of 9’ and 10’. 13C prediction was
consistent with the structure of 2 (Supplementary Figure 9), with
a mean error of 2.79 ppm between the observed and predicted
13C shifts.
A second isolation where no acidic conditions were used,
yielding 1, was also examined. 1H NMR revealed significantly
perturbed chemical shifts as well as line broadening and
heterogeneity throughout the spectra (Supplementary
Figure 11). Multiple resonances in the carbon spectrum
(Supplementary Figures 12, 13), especially for two resonances
in the carbonyl area (presumably C3 and C3’), are heterogenous,
reflecting the nuclei existing in several stable, but slightly
different micro environments. The same observation is made
in the proton spectrum (Supplementary Figure 11) for H9’,
OMe-6’, H5, H7, 4’-OH, and 4-OH. A major difference was
observed in the non-acidic preparation (1), compared to 2,
the presence of a 9’-OH. At ∼15 ppm, two heterogeneous OH
protons were observed, deshielded by approximately 1 ppm
compared to the OH-3’s in the original sample preparation,
while the three hydroxyls at ∼10 ppm could no longer be
detected (Supplementary Figures 8–13). Thus, the detectable
aromatic hydroxyl groups, identified as OH-4’ and OH-4,
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TABLE 1 | Summary of chemical shift and correlations for 2 (DMSO-d6).
Position δ13C, type δ1H, splitting (Hz) COSY HMBC (1H → 13C)
2 171.6, C – – –
2’ 171.0, C – – –
2a’ 99.4, C – – –
2a 99.2, C – – –
3 162.5, C – – –
3’ 161.5, C – – –
3a’ 108.6, C – – –
3a 107.5, C – – –
4 159.0, C – – –
4’ 154.9, C – – –
5’ 111.7, C – – –
5 102.1, CH 6.35, s – 3, 3a, 4, 6, 7
6 161.2, C – – –
6’ 160.7, C – – –
7a 140.6, C – – –
7a’ 140.1, C – – –
7 100.7, CH 6.04, s – 3, 3a, 5, 6, 8
7’ 99.7, CH 7.14, s – 3’, 3a’, 4’, 5’, 6’, 8, 8’
8a’ 137.4, C – – –
8a 132.9, C – – –
8 118.7, C – – –
8’ 117.5, CH 7.36, s – 2’, 3a’, 4’, 6’, 7’a, 7’, 9’
9’ 65.3, CH 4.69, d (J = 2.0) – 2a’, 8’, 8a’, 10’, 11’
9 31.0, CH2 2.59, m 10 2a, 7a, 8, 8a, 10, 11
10’ 83.2, CH 4.62, ddd (J = 7.9, 6.0, 2.0) 11’ 2’, 8a’, 9’, 11’, 12’
10 79.4, CH 4.56, dddd (J = 9.6, 7.4, 5.5, 4.1) 9, 11 2, 8a, 12
11 34.2, CH2 1.59, dd (J = 16.7, 9.5) 1.68, dd (J = 16.5, 4.0) 10, 12 10, 12
11’ 30.0, CH2 1.85, m 10’, 12’ 9’, 10’, 12’, 13’
12’ 24.7, CH2 1.48, 1.52, m 11’, 13’ 11’, 13’, 14’
12 24.5, CH2 1.27, 1.36, m 11, 13 11, 13, 14
13’ 31.3, CH2 1.23, m 12’, 14’ 11’, 12’, 14’, 15’
13 31.6, CH2 1.36, m 12, 14 11, 12, 14, 15
14’ 22.5, CH2 1.36, m 13’, 15’ 12’, 13’, 15’
14 22.4, CH2 1.24, m 15 12, 13, 15
15’ 14.4, CH3 0.92, m 14’ 13’, 14’
15 14.3, CH3 0.82, m 14 13, 14
16 56.5, O-CH3 3.77, s – 6’
OH3* – 13.71, s
OH3* – 13.62, s
OH4 – 9.80, s
OH4’ – 9.51, s
OH6 – 9.94, s
*Ambiguous assignment.
appeared to be involved in (stronger) hydrogen bonding, while
three aromatic hydroxyls, the remaining OH-6, OH-3’ and
OH-3, were unaccounted for. At the same time, the majority of
all other nuclei in the molecule are shielded by approximately
0.5 ppm. Together, these observations suggest that the neutral pH
preparation resulted in a different molecule, 1, that formed loose
aggregates in DMSO and methanol, stabilized by both hydrogen
bonding (deshielding) and stacking (shielding) interactions.
Overall, worse spectral quality resulted in that the C2 and C3
from 2 could not be individually assigned in 1, although they
must correspond to the two chemical shifts of 169.4 and 173 ppm
by the logic of elimination. A number of the carbons show
heterogenic peaks (notably the presumed C3 and C3’), most
likely as the result of through space proximity to the sulfate group
and sensitivity to its different possible conformation (details in
section “Discussion”).
The identity of 1 was established to be identical to 2
with the only difference being that the sulfate group was
attached to C6 instead of C9’, supported by the loss of the OH
correlating with H5 and H7, and the appearance of an OH
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FIGURE 3 | (i) Fragments identified for 2: (A,B) The napthopyrone-like moieties; (C) a sulfate group; (D) a spare hydroxyl group. (ii) Elucidated structure of 2: Bold
bonds = COSY, blue arrows = HMBC, and (iii) red arrows = weak 4JCH correlations, Bold bonds = 1,1-ADEQUATE.
correlating with H9’ through a 3JHH . There is furthermore a
heterogeneity and chemical shift perturbation hotspot (vis-à-vis
2) around the C6 position to support the assignment of a C6
sulfate. All chemical shifts and correlations are summarized in
Supplementary Table 3. The data do not unambiguously prove
whether the 3-OH’s are deprotonated or if the signal is lost due
to rapid exchange, but the fact that the OH-9’ is observable
under the same conditions is an indicium for the OH-3’s to be
deprotonated in 1. No plausible resonance structures to explain
the deprotonation and deshielding that does not involve the
oxidation, and thus change in mass, have been found.
The non-aggregated 2 could be scavenged by lowering the
pH of 1 with the addition of hydrochloric acid, upon which
1H and HSQC spectra of the two samples of 2 show a great
resemblance (Supplementary Figure 10). The molecular formula
of 2 and 1 as well as the scavenged 2 were identical in the
two preparations, as no change in mass was observed by high-
resolution mass spectrometry.
Antibacterial Activity Against Reference
and Clinical Strains
Compound 1 was tested against six reference bacteria (four
Gram-positive and two Gram-negative strains). The compound
was active against two of the Gram-positive reference strains,
S. aureus and S. agalactiae, with MIC values of 6.25 and
12.5 µg/ml, respectively. No activity was observed against
the Gram-negative strains, E. coli and P. aeruginosa, or the
Gram-positive E. faecalis or MRSA strain (Supplementary
Table 4). As bacterial resistance toward available antibiotics is
the main challenge in future treatment of pathogenic diseases,
1 was tested against a panel of drug-resistant clinical strains
(Supplementary Table 2). The panel included five MRSA and six
VRE strains. Compound 1 was also tested in a pre-screen against
four Gram-negative clinical bacterial strains: E. coli, Klebsiella
pneumoniae, Acinetobacter baumanii, and P. aeruginosa (all
ESBL-Carba). No activity was detected against the Gram-
negative bacteria (Supplementary Table 4). Compound 1 showed
activity against the MRSA strains with MICs in the 1.56–
6.25 µg/ml (2.12–8.44 µM) range, see Table 2. The activity of
the compound was significantly less profound against the VRE
strains (MIC = 50 µg/ml or higher) (Supplementary Table 4).
To investigate if 1 has bacteriostatic or bacteriocidal effects on
the two reference strains S. aureus and S. agalactiae, both were
incubated with the compound at 12.5 and 25 µg/ml overnight
and subsequently plated onto agar. For S. aureus, there was no
growth on the plates after overnight incubation, indicating a
bacteriocidal effect of 1. For S. agalactiae, one of the parallels at
12.5 µg/ml (MIC of 1 against this bacterium) displayed growth
on the agar plate, which was expected as visual growth could also
be seen in the microtiter plate for this parallel. The remaining
five parallels at this concentration, and the concentration above,
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had no growth in the microtiter plates, or on agar after overnight
incubation. This strongly indicates that 1 also has bacteriocidal
effect on S. agalactiae. Compound 1 was also tested together with
the efflux pump inhibitor reserpine to see if the lack of activity
toward Gram-negative strains was caused by efflux of 1, but no
activity was obtained.
Inhibition of Biofilm Production and
Eradication of Established Biofilm
The ability of 1 to inhibit biofilm production by S. epidermidis
and to remove established S. epidermidis biofilm was assessed.
In the biofilm inhibition assay, the biofilm production was
completely inhibited (below 5% biofilm formation) down to
12.5 µg/ml (Figure 4). Clear inhibition of the bacterial growth
could also be observed to 25 µg/ml by visual inspection of
plates before fixation of biofilm, raising the question if the
biofilm inhibition is mainly caused by growth inhibition of the
bacterium. To further evaluate the potential biofilm activity,
removal of established biofilm was assessed. There was no activity
of 1 at concentrations up to 100 µg/ml against the established
biofilm, further supporting the hypothesis that the biofilm
inhibition is mainly due to growth inhibition of the bacterium.
TABLE 2 | Minimal inhibitory concentrations (MICs) of 1 against reference strains
and clinical isolates.
Strain type Strain MIC in µg/ml
Clinical strains S. aureus N315 1.56
S. aureus 85/2082 3.13
S. aureus NCTC 10442 3.13
S. aureus WIS [WBG8318] 6.25
S. aureus IHT 99040 3.13
Reference strains S. aureus ATCC R© 25923 6.25
S. agalactiae ATCC R© 12386 12.5
The median MIC values are reported (n = 12 for clinical isolates, n = 9 for
reference strains).
FIGURE 4 | Inhibition of bacterial biofilm formation by 1 against the biofilm
producing S. epidermidis. *The bacterial growth was completely inhibited at
compound concentrations down to 25 µg/ml.
Antiproliferative Activity Against Human
Cells and Antifungal Activity
The antiproliferative activities of 1 was assessed against human
melanoma cells (A2058), human non-malignant lung fibroblasts
(MRC5), and human hepatocellular carcinoma cells (HepG2), in
a concentration range of 6.25–100 µg/ml. The non-malignant cell
line was included as a test for general toxicity, while the other
cell line was included to assess possible anti-cancer activities.
Antiproliferative activity was observed against all cell lines, with
IC50 values of 15.5, 32, and 27 µg/ml against A2058, MRC5, and
HepG2, respectively (Table 3). Compound 1 was also assayed
for antifungal activity against C. albicans at concentrations up to
100 µg/ml, and no activity was seen.
DISCUSSION
In this study, we describe the discovery, isolation, and
characterization of the new secondary metabolite lulworthinone
(1). This novel antibacterial compound was isolated from
an extract of a slow-growing marine fungus of the family
Lulworthiaceae. To the best of our knowledge, this is the first
reported secondary metabolite isolated from this fungal family
and the order Lulworthiales. Since the isolate did not branch close
to the Lulworthia type species, L. fucicola (in the Lulworthia sensu
stricto clade) and there was a lack of support at many nodes of
the phylogenetic tree, we restrained from identifying the isolate
067bN1.2 to genus and determine its identity to family level only.
A fraction of the Lulworthiaceae sp. extract was nominated for
chemical investigation as it was active in an initial antibacterial
screen. The content of the active Lulworthiaceae sp. fraction was
dominated by 1, whose calculated elemental composition gave no
hits in database searches, indicating that the compound suspected
to be responsible for the observed antibacterial activity, was
novel. In the attempt to utilize preparative HPLC to isolate this
compound, 2 was generated during the procedure (acidic mobile
phase). As compounds 1 and 2 have the same mass, HRMS
analysis did not detect the change in the positioning of the sulfate
group, and the sample from the preparative HPLC isolation was
characterized using NMR, believing it was 1. As preparative
HPLC was deemed inconvenient for compound isolation, flash
chromatography (neutral mobile phase) was utilized to isolate
sufficient amounts of 1 to conduct a thorough characterization of
the compound’s bioactivity. This method allows larger amounts
of sample to be processed per run, but generally is less effective
in separating compounds of interest from sample impurities,
compared to preparative HPLC isolation. However, due to
the high concentration of 1 in the extract, 1 was successfully
isolated using this method. The resulting sample was submitted
TABLE 3 | Antiproliferative activity (IC50) of 1 against human cell lines (n = 9).
Cell type IC50 in µg/ml
A2058, melanoma 15.5 ± 0.6
MRC5, normal lung fibroblasts 32 ± 1
HepG2, hepatocellular carcinoma 27 ± 1
Frontiers in Microbiology | www.frontiersin.org 10 October 2021 | Volume 12 | Article 730740
fmicb-12-730740 September 27, 2021 Time: 17:34 # 11
Jenssen et al. Lulworthinone, a New Antibacterial Naphthopyrone
to NMR analysis to confirm its structure. The samples from
both isolations were confirmed to be novel biarylic dimeric
naphtho-α-pyrones substituted with a sulfate group. However,
NMR analysis revealed that the sulfate group was located on
different positions in the two compounds. The rearrangement
was hypothesized to be catalyzed by the acidic nature of the HPLC
mobile phase. This hypothesis was confirmed by subjecting 1
to acidic conditions (Supplementary Figure 10). The resulting
sample was analyzed using NMR, confirming that 1 had indeed
converted into 2. As 2 was proven to be an artifact of 1,
all bioactivity testing was conducted using 1 isolated under
neutral conditions.
The propensity of 1 to interact with itself to form higher-
ordered structures, while 2 did not, offered some insight into
their structural behavior in solution. In particular, the sulfate in
the 6-position appeared to facilitate oligomeric aggregation, and
a simple 3D model allows some speculation as to why this could
be (Figure 5). The ground state of the naphthopyrone does not
have the ability to form complementary “base pairs” with itself
through hydrogen bonds between the carbonyls and hydroxyls.
However, when the sulfate is in the 6-position, it can reach the C3
double OH “mismatch” in the three-dimensional structure and
potentially stabilize the hydroxyls either by 4-coordnating a water
molecule or a Na+ ion together with deprotonated 3’-hydroxyls,
or by directly hydrogen bonding to the protonated hydroxyls.
This would provide a feasible rationale for the propensity for
aggregation of 1 but not of 2. The structural dimer model also
provides a plausible explanation as to why the sulfate group
would specifically and irreversibly migrate to C9’ under acidic
conditions even though the C9’ is expected to be a less likely
position for the sulfate than any other phenol position. The
sulfate is in an oligomeric state involving this kind of “base
pairing” positioned to be intermolecularly attacked by the OH-9’
of the paired molecule, which is not possible in the monomeric
state. Lowered pH is expected to ensure protonated sulfate,
which would make it more susceptible for an electrophilic attack
from OH-9’. If oligomeric states are indeed stabilized by the
coordination of water or sodium, then lowered pH and the
protonation of the 3- and 3’-oxygens would further destabilize
the oligomer, which together with the lack of stabilization from
the position 6 sulfate would make both the association and the
reaction irreversible and trap the sulfate in the 9’ position of
monomeric 2 with lowered ability to self-aggregate.
Lulworthia spp. fungi have spores with end chambers
containing mucus, which helps in spore attachment to surfaces
(Jones, 1994). It has been observed that in liquid culture of the
isolate 067bN1.2, the fungus forms a gel-like mucus, having the
ability to adhere to the bottom of the culture flasks. No spores
are formed in culture, and it remains unclear whether the mucus
formed under cultivation of 067bN1.2 has chemical resemblance
FIGURE 5 | Crude sculpted and minimized structural model of 1 displaying the sulfate potential role in stabilizing oligomerization, as well as the possibility to
intermolecularly react specifically at the C-9’ position to form 2 under acidic conditions.
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to the mucus in end chambers of Lulworthia spp. spores, as
it has not yet been characterized. The sheathing of mucoid by
L. medusa has been reported in a publication from 1973, where
the fungus was found and isolated from a piece of submerged pine
and cultivated in bottles in media supplemented with artificial
seawater (Davidson, 1973). Also in the current study, the fungus
was found to adhere to the culture flask during cultivation
in artificial seawater media. Davidson hypothesizes around
the physiological and ecological implications of the mucoid,
important in cation binding and transport, for the adhesion of
other microorganisms, avoiding desiccation in intertidal regions
or for the production of a matrix to concentrate exoenzymes
(Davidson, 1973). Compound 1 is isolated in high yields from
the fungal culture, but the ecological role of naphthopyrone-
type compounds is largely unclear. The antibacterial activity of
1, however, could indicate a protective role against pathogenic
attacks, but the compound may have other types of bioactivities
as well. It has been speculated that similar compounds (bis-
naphthopyrones) from filamentous ascomycetes were produced
to protect the fungus from predators (Xu et al., 2019). The study
found that several animal predators, like woodlice, preferred
feeding on fungi that had disrupted aurofusarin synthesis, and
also that predation stimulated the production of aurofusarin in
several Fusarium species (Xu et al., 2019). We have also observed
marine mites feeding on fruitbody contents of Lulworthiales
fungi. It is thus possible that in the natural habitat of these fungi,
the naphthopyrones are produced as a means of protection.
Compound 1 was found to be a dimeric biarylic naphtho-
α-pyrone substituted with a sulfate group. The naphthopyrone
moiety is recurring in nature, as monomers, dimers, and
trimers, and has been found from several natural sources,
like plants and filamentous fungi. Naphthopyrones have also
previously been isolated from organisms from the marine
environment (Li et al., 2016). Compounds from this class have
shown different bioactivities, among these the inhibition of
triacylglycerol synthesis (Kawaguchi et al., 2013), inhibition
of enzymatic activity (Zheng et al., 2007), protection against
animal predators (Xu et al., 2019), antimalarial activities
(Isaka et al., 2010), and antiproliferative activities (Isaka
et al., 2010; Li et al., 2016). Several of these compounds
have displayed antibacterial activities against Gram-positive
bacteria (Suzuki et al., 1992; Wang et al., 2003; Zheng et al.,
2007; Boudesocque-Delaye et al., 2015; Rivera-Chavez et al.,
2019). Lu et al. (2014) defined three groups of bis-naphtho-
γ-pyrones based on the diaryl bond connection between the
monomers, the chaetochromin-, asperpyrone-, and nigerone-
type bis-naphtho-γ-pyrones. Based on this categorization, 1
would be categorized as an asperpyrone-type bis-naphtho-
α-pyrone, due to the relative placement of the oxygen atoms
in the pyrone moieties. Compound 1 is substituted with a
sulfate group. One of the most abundant elements in seawater
is sulfur, and many sulfated compounds have been isolated
from marine organisms, mostly from marine invertebrates,
but also from microorganisms (Kornprobst et al., 1998;
Francisca et al., 2018). Compound 1 represents, however, the
first report of a dimeric naphtho-α-pyrone substituted with
a sulfate group.
In the current study, 1 was broadly assessed for potential
bioactivities: antibacterial activities against bacterial reference
strains and clinical strains, antiproliferative activities toward
a selection of human cell lines, both malignant and non-
malignant, anti-fungal activity, inhibition of bacterial biofilm
formation, and the eradication of established bacterial biofilm.
Intriguingly, 1 showed activity against multidrug-resistant MRSA
strains with MICs between 1.56 and 6.25 µg/ml (2.12–8.44 µM).
In comparison, a natural product originally isolated from
Clitophilus scyphoides (organism name at time of isolation:
Pleurotus mutilus, Basidiomycota) pleuromutilin showed MICs
in a similar range against selected reference strains (e.g.,
MIC = 0.66 µM against S. aureus, MIC = 2.64 µM against
K. pneumoniae, and MIC = 21.13 µM against B. subtilis) while
having significantly higher MIC values against other reference
strains (e.g., MIC ≥ 100 µM against P. aeruginosa) (Kavanagh
et al., 1951). An optimized analog of pleuromutilin, lefamulin
(Xenleta R©), was approved as an antibiotic drug by the US Food
and Drug Administration in 2019. The herein reported MIC
values thus place 1 in an activity segment, which makes it an
interesting candidate for further development toward becoming
a marketed antibiotic drug. In comparison to other antibacterial
napthopyrones, 1 falls within the same MIC range with regard
to activity toward Gram-positive bacteria. Two heterodimers,
isolated from the tubers of Pyrenacantha kaurabassana, showed
antibacterial activity against different strains of S. aureus with
MICs in the range of 2.7–89.9 µM (Boudesocque-Delaye et al.,
2015). In a recent paper from 2019, mycopyranone, a new
binaphthopyranone, was isolated from the fermentation broth
of Phialemoniopsis. The compound showed antibacterial activity
against both S. aureus and a MRSA strain, with MICs of≤8.7 µM
against both strains (Rivera-Chavez et al., 2019). Possibly
the most known naphthopyrone, viriditoxin showed MICs in
the 4–8 µg/ml range against different Staphylococcus isolates
(Wang et al., 2003).
Furthermore, the lack of activity against the Gram-negative
reference and clinical strains shows the selectivity of 1 against
Gram-positive bacteria. Yet, no activity or weak activity was
observed against the clinical VRE isolates and the reference
strain of E. faecalis, indicating that the activity is selective
toward groups of Gram-positives, in this case S. aureus and
S. agalactiae. Surprisingly, no activity was observed against the
reference MRSA strain, and the reason behind this is not clear.
No activity was observed for the combination of 1 and the efflux
pump inhibitor reserpine, indicating that the lack of susceptibility
by Gram-negatives is caused by another mechanism. In the
antiproliferative activity assay, the most potent activity of 1 was
observed against the melanoma cells (IC50 = 15.5 µg/ml). Against
the non-malignant lung fibroblasts, which were included as a test
for general toxicity, the compound had an IC50 of 32 µg/ml,
which is more than five times higher than the highest MIC
value against the multidrug-resistant MRSA. The concentrations
where 1 did not display any toxic effect on the cells (∼100%
cell survival) were 20, 12.5, and 15 µg/ml for MRC5, A2058,
and HepG2, respectively. This indicates that there is little overlap
between the concentration where 1 has antibacterial activity and
the concentration where toxicity occurs against the human cells.
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This observed difference is a good starting point when entering
structure optimization, as it indicates that production of non-
toxic variants of 1 can be obtained.
We isolated 45 mg/L of 1 when the Lulworthiaceae sp. fungus
was grown in liquid media supplemented with sea salts. This
shows that slow-growing marine fungi sensu stricto can produce
high yields of novel compounds for chemical characterization
and screening for biological activities. Compound 1 was found
to be a novel sulfated dimeric naphthopyrone, and showed
potent growth inhibition of multidrug-resistant MRSA with
MICs down to 1.56 µg/ml, which is much lower than the IC50
detected against the non-malignant cell line (32 µg/ml). This
study demonstrates that the family Lulworthiaceae and order
Lulworthiales have biosynthetic potential to produce bioactive
secondary metabolites and supports the view of Overy et al.
(2014) that marine fungi sensu stricto should be studied for
natural product discovery, despite their slow growth (Overy et al.,
2014). Our study highlights the potential role of marine fungi
sensu stricto in tackling the worldwide AMR crisis.
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